Glaxosmithkline
latest news & developmentsDrugmaker GlaxoSmithKlin logs slumping annual profits
Profit after tax sank to just under £4.4-billion (R91.21-billion) last year, the GSK said in a statement on Wednesday
SA, UK spearhead R500-million fund for joint scientific research
The two countries have set up the Newton Fund to focus on areas such as food security, the environment, and disease prevention and control.
Motsoaledi launches free HPV vaccine for schoolgirls
Health Minister Aaron Motsoaledi has launched an HPV vaccine programme for grade four girls in all government schools.
HIV research on monkeys makes breakthrough
A single shot of antiretroviral drugs has protected lab monkeys from HIV for weeks, according to two US trials.
There’s a new HIV drug – but Africa will have to wait
A new drug, Tivicay, that could be vital in the struggle against HIV, might not be available to those who need it the most.
Drug resistant Chinese bird flu raises concern
The new bird flu strain that has killed 36 people has proved resistant to Tamiflu for the first time, a development scientists find "concerning".
Pharmaceutical industry targets Africa’s growing middle class
According to data, by 2016 pharmaceutical spending in Africa is expected to reach $30-billion – driven by the continent’s increasing economic wealth.
Cervical cancer can be prevented
Cervical cancer is caused by a very common virus, but it is easy to detect and there is a vaccination for it, writes Mia Malan
Exposed: Bitter pill of bad pharma
A new book detailing how profit-hungry pharmaceutical companies mislead medical practitioners and harm patients may be just what the doctor ordered.
Pharmaceutical giant regrets corporate misconduct
GlaxoSmithKline has been fined $3-billion after admitting to encouraging the prescription of unsuitable antidepressants to children.
Identifying South Africa’s silent killers
Diseases with little or no symptoms are silently killing South Africans.
Breast is best – for slim adults
Exclusively breastfed babies are less likely to become obese adults, research has shown.
Big Pharma backs deal to boost flu pandemic readiness
Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic.
GlaxoSmithKline urged to pool its patents on HIV drugs
Leading UK and international organisations have written to Britain’s largest drug company urging it to pool its patents on HIV medicines.
Roche defends diet drug as FDA probes liver claim
There is no evidence of a link between weight loss drug Xenical and liver injury, drugmaker Roche said on Tuesday.